Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma

Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.43.1890
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

HER2/neu (ERBB2) Expression and Gene Amplification Correlates With Better Survival in Esophageal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Precision Medicine Approaches to Lung Adenocarcinoma With Concomitant MET and HER2 Amplification

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Esophageal Adenocarcinoma in a First-Degree Relative Increases Risk for Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus

United European Gastroenterology Journal
OncologyGastroenterology
2018English

Prevalence and Prognostic Significance of Neuroendocrine Cells in Esophageal Adenocarcinoma

Modern Pathology
Forensic MedicinePathology
2000English

Prognostic Impact of ANX7-GTPase in Metastatic and HER2-Negative Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2004English

Gene Amplification and Overexpression of HER2 in Renal Cell Carcinoma

BJU International
Urology
2008English

Salvage Endoscopic Resection in Patients With Esophageal Adenocarcinoma After Chemoradiotherapy

Endoscopy International Open
2018English

P1.05-018 Prognostic Impact of Tumor Shadow Disappearance Rate in Patients With Clinical IA Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

HER2 Amplification Has No Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Hereditary Cancer in Clinical Practice
OncologyGenetics
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy